These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3521484)

  • 1. Evaluation of pefloxacin in experimental Escherichia coli meningitis.
    Shibl AM; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1986 Mar; 29(3):409-11. PubMed ID: 3521484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of Morganella morganii meningitis with pefloxacin mesylate.
    Isaacs RD; Ellis-Pegler RB
    J Antimicrob Chemother; 1987 Nov; 20(5):769-70. PubMed ID: 3480886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of gatifloxacin in experimental Escherichia coli meningitis.
    Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ng W; Ghaffar F; McCracken GH
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1805-7. PubMed ID: 10390250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG; Shibl AM; Hackbarth CJ; Larrick JW; Sande MA
    J Infect Dis; 1987 Sep; 156(3):456-62. PubMed ID: 3302052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
    Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
    Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.
    Kern W; Kennedy SL; Sachdeva M; Sande ER; Gunderson D; Täuber MG
    Antimicrob Agents Chemother; 1990 May; 34(5):697-701. PubMed ID: 2163241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracameral penetration of pefloxacine in man].
    Bron A; Talon D; Delbosc B; Estavoyer JM; Prost F; Montard M
    J Fr Ophtalmol; 1986; 9(4):317-21. PubMed ID: 3495563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Bayer AS; Greenberg DP; Yih J
    Chemotherapy; 1988; 34(1):46-55. PubMed ID: 3162413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
    Beam TR; Allen JC
    Antimicrob Agents Chemother; 1980 Jan; 17(1):37-42. PubMed ID: 6986115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of pefloxacin.
    Husson MO; Izard D; Bouillet L; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
    McCracken GH; Sakata Y; Olsen KD
    Antimicrob Agents Chemother; 1985 Apr; 27(4):655-6. PubMed ID: 3890733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
    Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
    J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical uses of nalidixic acid analogues: the fluoroquinolones.
    Høiby N
    Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body].
    Denis F; Mounier M; Adenis JP
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):772-6. PubMed ID: 3309813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.